Pathway Financial Advisers LLC cut its position in MetLife, Inc. (NYSE:MET – Free Report) by 0.8% in the 4th quarter, Holdings Channel reports. The institutional investor owned 26,096 shares of the financial services provider’s stock after selling 215 shares during the quarter. Pathway Financial Advisers LLC’s holdings in MetLife were worth $2,137,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in MET. CWM LLC increased its holdings in shares of MetLife by 15.0% in the 3rd quarter. CWM LLC now owns 18,256 shares of the financial services provider’s stock worth $1,506,000 after purchasing an additional 2,383 shares in the last quarter. Ritholtz Wealth Management purchased a new stake in shares of MetLife during the 3rd quarter valued at about $214,000. Thurston Springer Miller Herd & Titak Inc. grew its stake in shares of MetLife by 54.5% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 757 shares of the financial services provider’s stock worth $62,000 after acquiring an additional 267 shares during the period. CX Institutional boosted its holdings in MetLife by 703.9% in the third quarter. CX Institutional now owns 58,668 shares of the financial services provider’s stock worth $4,839,000 after purchasing an additional 51,370 shares during the last quarter. Finally, Creative Planning grew its position in MetLife by 3.1% in the 3rd quarter. Creative Planning now owns 130,967 shares of the financial services provider’s stock worth $10,802,000 after purchasing an additional 3,964 shares during the period. Hedge funds and other institutional investors own 94.99% of the company’s stock.
Analyst Ratings Changes
A number of analysts recently commented on the company. Barclays reduced their price objective on MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, February 7th. TD Cowen increased their price objective on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, November 27th. JPMorgan Chase & Co. boosted their target price on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Keefe, Bruyette & Woods decreased their price target on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research report on Wednesday. Finally, BMO Capital Markets initiated coverage on MetLife in a research report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $92.17.
MetLife Stock Down 0.5 %
NYSE MET opened at $82.77 on Thursday. The stock has a 50 day moving average price of $83.54 and a 200-day moving average price of $81.00. MetLife, Inc. has a one year low of $67.04 and a one year high of $89.05. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The company has a market capitalization of $57.31 billion, a P/E ratio of 13.86, a P/E/G ratio of 0.64 and a beta of 1.07.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. As a group, equities analysts predict that MetLife, Inc. will post 9.63 EPS for the current fiscal year.
MetLife Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be given a dividend of $0.545 per share. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a yield of 2.63%. MetLife’s dividend payout ratio (DPR) is presently 36.52%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- ESG Stocks, What Investors Should Know
- Lattice Semiconductor’s Market Reset Is Over: The Rebound Begins
- CD Calculator: Certificate of Deposit Calculator
- Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Double-Digit Gains Ahead? These 2 Cybersecurity Stocks Look Ready
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.